ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression

American Journal of Physiology - Cell Physiology

Volumn 282, Issue 2 51-2, 2002, Pages

  Osses, Nelson ^a   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Extracellular matrix; Myogenin; Proteoglycan inhibitors; Proteoglycans; Satellite cells

Indexed keywords

CHLORATE; CREATINE KINASE; DYSTROGLYCAN; FIBRONECTIN; FOCAL ADHESION KINASE; GLYPICAN; LAMININ; MUSCLE PROTEIN; MYOGENIN; PROTEOGLYCAN; SODIUM CHLORATE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; SKELETAL MUSCLE;

ANIMALIA;

EID: 0036086733     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00322.2001     Document Type: Article

References (62)

1. Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes
2. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation
3. Functions of cell surface: Heparan sulfate proteoglycans
4. Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation
5. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle
6. Synthesis and processing of glypican during differentiation of skeletal muscle cells
7. Heparan sulfate proteoglycans during terminal skeletal muscle cell differentiation: Possible functions and regulation of their expression
8. Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor
9. Cell surface receptors for extracellular matrix molecules
10. The alpha7beta1 integrin in muscle development and disease
11. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice
12. Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle
13. A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells. Isolation and biochemical characterization
14. Integrins and signal transduction pathways: The road taken
15. Expression of alpha 1 integrin, a laminin-collagen n receptor, during myogenesis and neurogenesis in the avian embryo
16. Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells
17. Muscle regeneration by bone marrow-derived myogenic progenitors
18. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells
19. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism
20. Skeletal myogenic potential of human and mouse neural stem cells
21. Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development
22. Muscle regeneration: Molecular aspects and therapeutic implications
23. Inhibition of proteoglycan synthesis alters extracellular matrix deposition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture
24. Temporal and quantitative analysis of myogenic regulatory and growth factor gene expression in the developing mouse embryo
25. The influence of collagen on the development of muscle clones
26. Mutations in the integrin alpha7 gene cause congenital myopathy
27. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies
28. Chlorate: A reversible inhibitor of proteoglycan sulfation
29. Growth factors in skeletal muscle regeneration
30. Integrins: A family of cell surface receptors
31. Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle
32. Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases
33. A simple, rapid, and sensitive DNA assay procedure
34. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation
35. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism
36. Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid
37. Wiring diagrams: Regulatory circuits and the control of skeletal myogenesis
38. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal
39. A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation
40. Transcription factor families: Muscling in on the myogenic program
41. Noncoordinate developmental regulation of N-cadherin, N-CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation
42. Extracellular matrix is required for skeletal muscle differentiation but not myogenin expression
43. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation
44. Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo
45. Ethyl-3,4-dihydroxybenzoate inhibits myoblast differentiation: Evidence for an essential role of collagen
46. MEF2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation
47. FGF-4 and BMP-2 have opposite effects on limb growth
48. Expression and localization of proteoglycans during limb myogenic activation
49. Developmental regulation of laminin accumulation in the extracellular matrix of a mouse muscle cell line
50. Distribution of insulin-like growth factor peptides in the developing chick embryo
51. MyoD meets its maker
52. Antisense inhibition of decorin expression in myoblasts decreases cell responsiveness to transforming growth factor β and accelerates skeletal muscle differentiation
53. Proteoglycans as modulators of growth factor activities
54. The molecular regulation of myogenesis
55. cis-4-hydroxy-L-proline and ethyl-3,4-dihydroxybenzoate prevent myogenesis of C2c12 muscle cells and block MyoD1 and myogenin expression
56. Focal adhesion kinase and associated proteins
57. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: Involvement of the Grb2, p130cas, and Nck adaptor proteins
58. A new look at the origin, function, and "stem-cell" status of muscle satellite cells
59. 1-Integrin and PI 3-kinase regulate RhoA-dependent activation of skeletal α-actin promoter in myoblasts
60. Integrin signaling
61. Cell heterogeneity upon myogenic differentiation: Down-regulation of MyoD and Myf-5 generates "reserve cells"
62. Skeletal muscle determination and differentiation: Story of a core regulatory network and its context